πŸ‡ΊπŸ‡Έ FDA
Patent

US 7897152

Viral chemokine-antigen fusion proteins

granted A61KA61K2039/505A61K39/39541

Quick answer

US patent 7897152 (Viral chemokine-antigen fusion proteins) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K2039/505, A61K39/39541, A61P, A61P31/12